Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility Study of Redormin® 500 on Day-time Cognition in Occasional Sleep Problems
NCT05684523Phase 4Completed
- Sponsor
- Max Zeller Söhne
- Start
- Mar 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Alluna in sleep disorder, sponsored by Max Zeller Söhne. Started Mar 2023; status: completed.
02
Drugs
Alluna
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT05684523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05684523.